Prolonged High‐Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary Percutaneous Coronary Intervention: Novel Insights From an Updated Meta‐Analysis

MLA

Gregor Fahrni, et al. “Prolonged High‐Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary Percutaneous Coronary Intervention: Novel Insights From an Updated Meta‐Analysis.” Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, vol. 5, no. 7, July 2016. EBSCOhost, https://doi.org/10.1161/JAHA.116.003515.

APA

Gregor Fahrni, Mathias Wolfrum, Giovanni Luigi De Maria, Adrian P. Banning, Umberto Benedetto, & Rajesh K. Kharbanda. (2016). Prolonged High‐Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary Percutaneous Coronary Intervention: Novel Insights From an Updated Meta‐Analysis. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 5(7). https://doi.org/10.1161/JAHA.116.003515

Chicago

Gregor Fahrni, Mathias Wolfrum, Giovanni Luigi De Maria, Adrian P. Banning, Umberto Benedetto, and Rajesh K. Kharbanda. 2016. “Prolonged High‐Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary Percutaneous Coronary Intervention: Novel Insights From an Updated Meta‐Analysis.” Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 5 (7). doi:10.1161/JAHA.116.003515.